Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
First-line therapy
CLINICAL PEARLS In advanced non−small cell lung cancer, when an actionable oncogenic driver is present, regardless of the PD-L1 tumor proportion score (TPS), targeted therapy is the preferred option. In the absence of an oncogenic driver, currently PD-L1 TPS drives…